Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Arrhythmia/Electrophysiology
Clinical and Electrocardiographic Characteristics of Electrical Storms Due to Monomorphic Ventricular Tachycardia Refractory to Intravenous Amiodarone
Hiroshige MurataYasushi MiyauchiMeiso HayashiYu-ki IwasakiKenji YodogawaAkira UenoHiroshi HayashiIppei TsuboiShunsuke UetakeKenta TakahashiTeppei YamamotoMitsunori MaruyamaKoichi AkutsuTakeshi YamamotoYoshinori KobayashiKeiji TanakaHirotsugu AtarashiTakao KatohWataru Shimizu
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2015 Volume 79 Issue 10 Pages 2130-2137

Details
Abstract

Background:Few reports are available on the characteristics of electrical storms of ventricular tachycardia (VT storm) refractory to intravenous (IV) amiodarone.Methods and Results:IV-amiodarone was administered to 60 patients with ventricular tachyarrhythmia between 2007 and 2012. VT storms, defined as 3 or more episodes of VT within 24 h, occurred in 30 patients (68±12 years, 7 female), with 12 having ischemic and 18 non-ischemic heart disease. We compared the clinical and electrocardiographic characteristics of the patients with VT storms suppressed by IV-amiodarone (Effective group) to those of patients not affected by the treatment (Refractory group). IV-amiodarone could not control recurrence of VT in 9 patients (30%). The Refractory group comprised 5 patients with acute myocardial infarctions. Although there was no difference in the VT cycle length, the QRS duration of both the VT and premature ventricular contractions (PVCs) followed by VT was narrower in the Refractory group than in the Effective group (140±30 vs. 178±25 ms, P<0.01; 121±14 vs. 179±22 ms, P<0.01). In the Refractory group, additional administration of IV-mexiletine and/or Purkinje potential-guided catheter ablation was effective.Conclusions:IV-amiodarone-refractory VT exhibited a relatively narrow QRS tachycardia. The narrow triggering PVCs, suggesting a Purkinje fiber origin, may be treated by additional IV-mexiletine and endocardial catheter ablation. (Circ J 2015; 79: 2130–2137)

Content from these authors
© 2015 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top